Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLINICAL PHASE 2 MULTICENTER TRIAL OF PF-00299804 IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

NCT00768664 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00768664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00768664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLINICAL PHASE 2 MULTICENTER TRIAL OF PF-00299804 IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
November 4, 2008
Completion date
April 18, 2012
Enrollment
69 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck neoplasms